A critical advance in cancer research is emerging with the use of VHH fragments to re-engage damaged p53. This crucial cancer inhibitor protein is frequently lost in various kinds of tumors, resulting uncontrolled https://bookmarklinking.com/story363622/nanobodies-reactivate-p53-the-potential-approach-for-malignant-management